HK1130903A1 - 以鱗狀上皮細胞癌抗原為指標的肌膚敏感性程度的評價方法 - Google Patents

以鱗狀上皮細胞癌抗原為指標的肌膚敏感性程度的評價方法

Info

Publication number
HK1130903A1
HK1130903A1 HK09108948.7A HK09108948A HK1130903A1 HK 1130903 A1 HK1130903 A1 HK 1130903A1 HK 09108948 A HK09108948 A HK 09108948A HK 1130903 A1 HK1130903 A1 HK 1130903A1
Authority
HK
Hong Kong
Prior art keywords
cell carcinoma
squamous cell
indication
sensitivity level
related antigen
Prior art date
Application number
HK09108948.7A
Other languages
English (en)
Inventor
Chika Katagiri
Jotaro Nakanishi
Toshihiko Hibino
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of HK1130903A1 publication Critical patent/HK1130903A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK09108948.7A 2006-03-17 2009-09-28 以鱗狀上皮細胞癌抗原為指標的肌膚敏感性程度的評價方法 HK1130903A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006075024 2006-03-17
PCT/JP2007/055926 WO2007108523A1 (ja) 2006-03-17 2007-03-15 扁平上皮細胞癌関連抗原を指標とする肌の感受性の程度の評価方法

Publications (1)

Publication Number Publication Date
HK1130903A1 true HK1130903A1 (zh) 2010-01-08

Family

ID=38522549

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108948.7A HK1130903A1 (zh) 2006-03-17 2009-09-28 以鱗狀上皮細胞癌抗原為指標的肌膚敏感性程度的評價方法

Country Status (8)

Country Link
US (1) US20090208985A1 (zh)
EP (1) EP1995595B1 (zh)
CN (1) CN101405601B (zh)
AT (1) ATE529745T1 (zh)
ES (1) ES2375662T3 (zh)
HK (1) HK1130903A1 (zh)
TW (1) TWI444618B (zh)
WO (1) WO2007108523A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2923610B1 (fr) * 2007-11-14 2009-11-27 Galderma Res & Dev Methode non-invasive de recueil de donnees biologiques pour l'etablissement d'un diagnostic d'une pathologie cutanee.
JP5775540B2 (ja) * 2013-02-22 2015-09-09 株式会社ファンケル 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10221340A (ja) * 1997-02-07 1998-08-21 Advanced Sukin Res Kenkyusho:Kk 皮膚疾患の診断方法および薬効評価方法
EP1356298B1 (en) * 2000-11-30 2011-05-18 Crawford Healthcare Holdings Limited Diagnosis of disease
JP3863462B2 (ja) * 2002-06-24 2006-12-27 株式会社資生堂 皮膚疾患および敏感肌の検査方法ならびにその方法に利用するキット
JP2005272343A (ja) * 2004-03-24 2005-10-06 Shiseido Co Ltd 紫外線誘導アポトーシスの抑制方法
KR101286833B1 (ko) * 2005-03-18 2013-07-17 가부시키가이샤 시세이도 편평상피세포암 관련 항원을 지표로 하는 피부 성상의 평가방법

Also Published As

Publication number Publication date
WO2007108523A1 (ja) 2007-09-27
EP1995595A1 (en) 2008-11-26
ES2375662T3 (es) 2012-03-05
EP1995595A4 (en) 2009-06-17
EP1995595B1 (en) 2011-10-19
ATE529745T1 (de) 2011-11-15
CN101405601B (zh) 2014-05-14
CN101405601A (zh) 2009-04-08
TWI444618B (zh) 2014-07-11
US20090208985A1 (en) 2009-08-20
TW200804806A (en) 2008-01-16

Similar Documents

Publication Publication Date Title
EP1860437A4 (en) METHOD FOR EVALUATING SKIN CONDITION USING AS AN ANTIGEN ASSOCIATED WITH CARCINOMA OF SQUAMOUS CELLS
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
WO2008027098A3 (en) Biosensor for measurement of species in a body fluid
GB2474146A (en) Methods of determining the health status of an individual
WO2010091410A3 (en) Improvements in and relating to microfluidic devices for processing a sample
HK1172229A1 (zh) 用於測定分析物濃度的光學傳感器
DK1868498T3 (da) Sensor til detektering af kropsparametre samt fremgangsmåde til detektering af kropsparametre
IL192166A0 (en) Novel quantitative and qulitative analysis apparatus for measuring the body fluid
IN2013CN01129A (zh)
EP2021794B8 (en) Use of protein s100a 12 as a marker for colorectal cancer
MX2009011307A (es) Metodos para contar celulas.
EP1958566A4 (en) VOLTAGE MEASURING APPARATUS THAT PERMITS EXACT VOLTAGE MEASUREMENT
ATE554389T1 (de) Apex als marker für lungenkrebs
ATE493290T1 (de) Alcotestgerät
EP1970003A4 (en) DEVICE FOR ACCURATELY MEASURING THE BODY COMPOSITION OF THE WHOLE BODY WITH SIMPLIFIED OPERATION
PL2040072T3 (pl) System analityczny do określania koncentracji analitu w płynie ustrojowym
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
MX2016005313A (es) Deteccion de la actividad de corte de una enzima.
TW200636473A (en) Configuration device and method for current output at USB port
HK1130903A1 (zh) 以鱗狀上皮細胞癌抗原為指標的肌膚敏感性程度的評價方法
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
MX2009009114A (es) Tira de prueba con lanceta integrada.
WO2009021908A3 (en) Disposable enzymatic sensor for liquid samples
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210315